THE CLINICAL-VALUE OF INTERFERONS AS ANTI-TUMOR AGENTS

被引：60
作者：
BILLIAU, A
机构：
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1981年 / 17卷 / 09期
关键词：
D O I：
10.1016/S0014-2964(81)80001-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：949 / 967
页数：19
相关论文
共 130 条
[1]   SENSITIVITY OF EPSTEIN-BARR VIRUS TRANSFORMED HUMAN LYMPHOID-CELL LINES TO INTERFERON [J].
ADAMS, A ;
STRANDER, H ;
CANTELL, K .
JOURNAL OF GENERAL VIROLOGY, 1975, 28 (AUG) :207-217
[2]  
ATALLAH AM, 1979, INT ARCH ALLERGY, V60, P377
[3]   HUMAN-LYMPHOBLASTOID INTERFERON CAN INHIBIT THE GROWTH OF HUMAN-BREAST CANCER XENOGRAFTS IN ATHYMIC (NUDE) MICE [J].
BALKWILL, F ;
TAYLORPAPADIMITRIOU, J ;
FANTES, KH ;
SEBESTENY, A .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (04) :569-573
[4]  
BERGERET M, 1980, IMMUNOLOGY, V40, P637
[5]   INTERFERON THERAPY IN MULTIPLE-MYELOMA - FAILURE OF HUMAN FIBROBLAST INTERFERON ADMINISTRATION TO AFFECT THE COURSE OF LIGHT CHAIN DISEASE [J].
BILLIAU, A ;
BLOEMMEN, J ;
BOGAERTS, M ;
CLAEYS, H ;
VANDAMME, J ;
DELEY, M ;
DESOMER, P ;
DROCHMANS, A ;
HEREMANS, H ;
KRIEL, A ;
SCHETZ, J ;
TRICOT, G ;
VERMYLEN, C ;
VERWILGHEN, R ;
WAER, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (08) :875-882
[6]   HUMAN FIBROBLAST INTERFERON FOR CLINICAL-TRIALS - PRODUCTION, PARTIAL-PURIFICATION, AND CHARACTERIZATION [J].
BILLIAU, A ;
VANDAMME, J ;
VANLEUVEN, F ;
EDY, VG ;
DELEY, M ;
CASSIMAN, JJ ;
VANDENBERGHE, H ;
DESOMER, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (01) :49-55
[7]   INTERFERON THERAPY - PHARMACOKINETIC AND PHARMACOLOGICAL ASPECTS - BRIEF REVIEW [J].
BILLIAU, A .
ARCHIVES OF VIROLOGY, 1981, 67 (02) :121-133
[8]   HUMAN FIBROBLAST INTERFERON FOR CLINICAL-TRIALS - PHARMACOKINETICS AND TOLERABILITY IN EXPERIMENTAL-ANIMALS AND HUMANS [J].
BILLIAU, A ;
DESOMER, P ;
EDY, VG ;
DECLERCQ, E ;
HEREMANS, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (01) :56-63
[9]  
BLOMGREN H, 1976, ACTA MED SCAND, V199, P527
[10]  
BORDEN EC, 1981, 1980 P C CLIN POT IN
12345678910